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Abstract.  Two mAbs, one specific for cardiac a-myo- 
sin heavy chains (MHC) and the other specific for 
cardiac 13-MHC, were used to investigate the heavy- 
chain dimeric organization of rat cardiac ventricular 
myosin. Epitopes of the two mAbs were mapped on 
the myosin molecule by electron microscopy of rotary 
shadowed mAb-myosin complexes, mAbs were clearly 
identifiable by the different locations of their binding 
sites on the myosin rod. Thus, myosin molecules 
could be directly discriminated according to their 
r  or I3-MHC content. 0m-MHC and [313-MHC homo- 
dimers were visualizeA  in complexes consisting of two 
molecules of the same mAb bound to one myosin mol- 
ecule. By simultaneously using the ot-MHC-specific 
mAb and the 13-MHC-specific  mAb, r  hetero- 
dimers were visualized in complexes formed by one 
molecule of each of the two mAbs bound to one myo- 
sin molecule. Proportions of r  and I]I3-MHC homo- 
dimers and r  heterodimers were estimated 
from quantifications of mAb-myosin complexes and 
compared with the proportions given by electro- 
phoreses under nondenaturing conditions. This 
visualization of cardiac myosin molecules clearly 
demonstrates the arrangement of ~t- and 13-MHC in 
0t0t-MHC homodimers, 13~MHC homodimers, and 
r  heterodimers, as initially proposed by Hoh, 
J. E  Y., G. P. S. Yeoh, M.  A. W. Thomas, and 
L. Higginbottom (1979). 
T 
HE myosin molecule is a hexamer, consisting of two 
heavy chains and four light chains, and is highly poly- 
morphic. The evidences of the multiple forms of myo- 
sin in the heart were revealed in the rabbit by peptide mapping 
(Flink and Morkin, 1977), and in the rat by immunological 
techniques (Schwartz et al.,  1978) and nondenaturing elec- 
trophoresis (Hoh et al., 1978). The polymorphism of cardiac 
myosin arises from the occurrence of two heavy-chain iso- 
forms, called r  and 13, which were first demonstrated in the 
rat (Hoh et al.,  1979). It has been found later that r  and 
13-myosin heavy chains (MHCs) ~  are encoded by two differ- 
ent genes in the rat (Mahdavi et al., 1982) and rabbit (Sinha 
et al.,  1982). No complete amino acid sequence of cardiac 
MHC has yet been published, but partial r  and I~-MHC pri- 
mary sequences have either been deduced from nucleotide 
sequences or determined from peptide fragments in various 
species (Mahdavi et al., 1982; Sinha et al., 1982; Flink and 
Morkin, 1984; Kavinsky et al., 1984; Mahdavi et al., 1984; 
Sinha et al., 1984; Lichter et al., 1986; Liew et al., 1986). 
These sequences indicate a great homology between 0t- and 
13-MHC. Functionally speaking, myosin with a-MHC has a 
Ca  2§ ATPase activity that is three times higher than that of 
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1. Abbreviation  used in this paper:  MHC, myosin heavy chain. 
myosin with 13-MHC (Pope et al., 1980). The physiological 
importance of the two MHC isoforms, which differ in their 
primary structures and enzymatic activities, is suggested by 
the fact that their expression varies according to animal spe- 
cies, development, hormonal state, hemodynamic  character- 
istics,  and intramyocardial  localization  (for a  review  see 
Swynghedauw,  1986). 
A series of reports using immunolabeling in different spe- 
cies indicate that a- and 13-MHC can be expressed not only 
in separate fibers but also in the same cardiac fiber (Samuel 
et al.,  1983; Bouvagnet et al.,  1984; Gorza et al.,  1984; 
Tsuchimochi et al., 1984; Yazaki et al., 1984; Bouvagnet et 
al., 1985; Dechesne et al., 1985b; Everett,  1986; Kuro-o et 
al.,  1986; Dechesne et  al.,  1987). The  coexpression  of 
r  and I]-MHC in the same fiber raises the question of the 
relative arrangement  of  these MHC in such fibers. On the ba- 
sis of  electrophoretic separation of  rat ventricular myosin  un- 
der nondenaturing conditions into three bands, V~, V2, and 
V3,  Hoh et al.  (1979) have proposed that ~t- and 13-MHC 
can be arranged in three forms: r  homodimers, r 
MHC heterodimers, and 1313-MHC homodimers, respective- 
ly. Thus, according to these results, when ~t- and I3-MHC are 
expressed in separate fibers, they are necessarily expressed 
in homodimeric forms; but when r  and 13-MHC are coex- 
pressed in the same fiber, it is not known whether myosin oc- 
curs in the form of a mixture of ~ta- and I]I~-MHC homo- 
dimers, or only a~MHC heterodimers, or both. In addition, 
the existence of ul3-MHC heterodimers raises the problem 
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thick filaments. Therefore the homodimeric and/or heterodi- 
meric organization of a- and [I-MHC is a very important as- 
pect of the understanding of the functional role of cardiac 
myosin isoforms at the molecular level. 
mAbs raised against cardiac MHC isoforms were used in 
electron  microscopy after  rotary  shadowing  (Slayter and 
Lowey, 1967; Walzth6ny et al., 1983) to investigate the homo- 
dimeric and heterodimeric MHC organization of rat cardiac 
ventricular myosin. By simultaneously labeling myosin mol- 
ecules with one a-MHC-specific rnAb (designated here as 
anti-a) and one 13-MHC-specific  mAb (designated here as 
anti-[I),  we were able to visualize both aa- and [I[I-MHC 
homodimers and aI~-MHC heterodimers. The proportions of 
aa-,  ~ff, and al3-MHC dimers were determined in three 
myosins exhibiting either one V~  band,  one V3 band,  or 
three VIV2V3 bands on electrophoresis under nondenatur- 
ing conditions. This work constitutes a visual demonstration 
of the existence of  the three possible molecular arrangements 
of a- and ~-MHC proposed by Hoh et al. (1979). 
Materials and Methods 
Protein Preparation 
Cardiac ventricles from W~star male rats were frozen in liquid nitrogen and 
stored at  -800C until use. Ventricular myosin was prepared according to 
Kieily and Bradley (1956) from three kinds of hearts: hearts from 20- to 
25-d-old rats, hearts from 6-too-old rats, and hearts from rats thyroidec- 
tomized at 3 mo and killed at 7 mo of age. The three corresponding myosin 
preparations produced one Vt  band,  three VIV~V3 bands,  and one V3 
band, respectively, on nondenaturing electrophoretic gels (data not shown), 
in agreement with the original results of Hoh et al. (1978). These myosins 
will here be referred to as V~, VtV2V3, and V3 myosins, respectively. Den- 
sitometric scanning of the V~V~V3 myosin showed 51, 29, and 20% of the 
proteins in the V~, V~, and V3 bands, respectively. 
Production and characterization of mAb have been described previously 
(Bouvagnet et al., 1984; Dechesne et al., 1985a).  The two mAbs used here 
belong to mAb populations whose ct-MHC or [I-MHC specificities have 
been demonstrated  by various independent methods: Western blot, competi- 
tive radioimmunoassay, immunofluorescence, and immunoaflinity chroma- 
tography (Bouvagnet et al., 1985; Dechesne et al., 1985a; Dechesne et al., 
1985b;  L~ger et al.,  1985; Dechesne et al.,  1987). 
Immunoelectron Microscopy and Statistical Analysis 
Preparation of myosin and mAb samples, rotary shadowing of mAb-myosin 
complexes, and measurements of myosin molecules have been described 
previously (Claviez et al., 1982; Dechesne et al., 1985a).  mAb concentra- 
tions (200-500 p,g/ml) always exceeded  the myosin concentrations (100-200 
gg/ml). Epitope location is designated by the distance between the head-tail 
junction of the myosin molecule and the mAb binding site, expressed as the 
mean +  SD (nm). To eliminate the nonspeeific mAb binding background, 
mAb binding sites were included in statistical calculations only if they were 
found at least three times at the same distance from the head-tail junction. 
The theoretical randomly distributed proportions of the different possible 
types of mAb-myosin  complexes were calculated under the assumption that 
the binding of two mAbs to the same myosin molecule constituted two inde- 
pendent events. When the anti-a and anti-13 were incubated together with 
the V1V2V3 myosin, the proportions were determined using the following 
probability equations: 
q0o =  Q~ (1 -  pQ)2 =  QI313 (1 -  pl~)  2 +  (1  -  Q,~ -  Ql~ll) (1  -  p,)(1  -  PI~); 
q~o =  2  Q~ap~ (1  -  pa)  +  (1  -  Q.~  -  Qaa) p, (1  -  p13); 
q2o =  Q,~ p,2; 
q0~  =  2 Q~pa (1  -  pa)  +  (1  -  Q~  -  Qaa) pa (1  -  p~); 
q02  =  QI31~  p2; 
qll  =  (1  -  Q~o  -  Qaa)p~pa, 
where qu is the proportion of myosin molecules labeled by i anti-a mole- 
cules and j  anti-IS molecules per myosin molecule (i and j  =  0-2), Qo~ is 
the proportion of aa-MHC,  Q~ is the proportion of 13~-MHC, p, is the 
probability of anti-a binding to its epitope, and p~ is the probability of 
anti-~ binding to its epitope. The probabilities p, and p~ were obtained by 
labeling V~  or V3 myosin with only anti-a or anti-13, respectively (see 
Results). The proportions Qo~ and Q~ were determined by densitometric 
scanning of the V~ and V3 bands of myosin separated on denaturing dec- 
trophoretic gels (see above), because these bands are considered to consist 
of act- and 131~-mHC homodimers, respectively (Hoh et al.,  1979). Thus, 
for VIV2V3 myosin, QQ, =  0.51 and Q~o =  0.20. 
When only anti-a was incubated with Vl myosin, the same calculations 
were done with Q~a  =  1 and Q~  =  0.  When only anti-13 was incubated 
with V3 myosin, the  same calculations  were done with  Q.~  =  0  and 
QI31~ ---  1. 
The theoretical and observed proportions were compared by a chi-square 
test. 
Results 
Binding Characteristics  of mAbs to Myosin Molecules 
Two mAbs raised against cardiac MHC isoforms were se- 
lected on the basis of their MHC specificities and epitope lo- 
cations. One mAb is specific for a-MHC, the other is spe- 
cific for [I-MHC  (see Materials and Methods).  They are 
designated here as anti-a and anti-[I, respectively. To locate 
their epitopes, myosin molecules from rat cardiac ventricles 
were examined by electron microscopy after rotatory shad- 
owing of mAb--myosin complexes.  Fig.  1 shows  electron 
micrographs of single-myosin molecules, complexed with 
either anti-a or anti-[I. The binding characteristics of anti-a 
were determined on V~ myosin and the binding characteris- 
tics of anti-[I were determined on V3 myosin. As expected, 
one or two mAb molecules were able to bind to one myosin 
molecule, because of the heavy-chain dimeric structure of 
myosin. The locations of the mAb binding sites on myosin 
molecules shown in the histograms in Fig.  1 were statisti- 
cally analyzed. The epitope of anti-a was located at 62.7  + 
5.3 nm (n =  54) from the head-tail junction and the epitope 
of anti-[I was located at 36.3  +  4.5 nm (n =  45) from the 
same origin. Thus, anti-a and anti-[I were easily distinguished 
because of the distance between their epitopes on the myosin 
molecules.  For each mAh the same epitope location was 
found with one or two mAb molecules bound to a myosin 
molecule. 
The distribution of myosin molecules observed with zero, 
one, or two epitopes occupied by either mAh is shown in Ta- 
ble I. These data indicate a lower affinity of anti-a for Vt 
myosin than of anti-[I  for V3 myosin, under these condi- 
tions.  The probability of a  mAb occupying its epitope is 
given by the ratio (2n2 +  nO/2n, where n2 and nl indicate 
the number of myosin molecules with two or one epitopes 
occupied, respectively, and n is the total number of myosin 
molecules observed. The probabilities for anti-a and anti-13 
were p~  =  0.51 and p~  =  0.93,  respectively.  Previous 
results have evidenced a slight contamination of rat V~ myo- 
sin by 8 +  5 % of myosin with [l-heavy chains (Dechesne et 
al.,  1987). This  observation was confirmed here.  Conse- 
quently, when calculating the probability of anti-a binding 
to an a-MHC, n was decreased by 8%  to account for the 
small amount of [I-MHC. Using the probability equations de- 
scribed in Materials and Methods, we calculated the ran- 
domly distributed proportions of uncomplexed myosin mole- 
cules and mAb-myosin complexes with one and with two 
mAbs per myosin molecule. There is no significant differ- 
ence (P =  0.05) between the theoretical values and the oh- 
The Journal  of Cell Biology,  Volume 105, 1987  3032 Figure 1. Electron micrographs of rotary-shadowed replicas of ventricular myosin molecules. On the left two myosin molecules are shown 
with no mAb labeling,  in the middle they are labeled by anti-a, and on the right they are labeled by anti-13. One (top) or two (bottom) 
mAb molecules can bind to myosin molecules. Histograms represent, from left to right, the distribution of measurements of  the rod lengths 
(146.5 +  2.8 nm), the distances from the head-tail junction  to the anti-a binding site (62.7 +  5.3 nm), and anti-I~ binding site (36.3 + 
4.5 nm).  Bar, 25 nm. 
served values, either for anti-a or anti-13 (see Table I). This 
supports the conclusion that anti-a or anti-13 binding is inde- 
pendent of previous binding to myosin by another molecule 
of the same mAb. 
Visualization of  Myosin Heavy Chain Heterodimers 
To obtain a  double immunolabeling of myosin, anti-a and 
Table L Binding Characteristics of  mAbs 
to Myosin Molecules 
Number of mAbs 
per myosin molecule  0  1  2 
Anti-a/V 1 myosin 
Observed  30  45  25 
(Theoretical)  (24)  (50)  (26) 
Anti-13/V3 myosin 
Observed  2  9  89 
(Theoretical)  (1)  (13)  (86) 
The table indicates the observed and theoretical distributions of percentages of 
rotary-shadowed myosin molecules bound by zero, one, or two mAbs. The 
binding of anti-a and anti-13 was analyzed in Vj (n =  157) and V3 (n =  125) 
myosins, respectively. The theoretical randomly distributed proportions are in 
parentheses. 
anti-13 were incubated together with VIV~V3 myosin. Only 
myosin molecules bound with two mAbs can provide infor- 
mation about the homodimeric or heterodimeric heavy-chain 
structure of myosin. Three types of rotary shadowed mAb- 
myosin complexes with two mAbs per myosin molecule were 
detected by electron microscopy. The first and second types 
were myosin molecules bound with two anti-a or two anti-13, 
respectively, as shown above (Fig.  1). The two anti-a mAb 
molecules on the same site were identified by the location of 
their binding sites at 63.5  -1- 5.1  nm (n  =  38), and the two 
anti-13 mAb molecules on the same site by the location of 
their binding sites at 37.4 5= 3.3 nm (n =  46). Myosin mole- 
cules labeled with two anti-a were consequently aa-MHC 
homodimers and myosin molecules labeled with two anti-13 
were 1313-MHC homodimers. The third type corresponded to 
myosin molecules bound with one anti-a and one anti-13. The 
latter type of mAb-myosin complex is illustrated in the gal- 
lery and chart of Fig.  2.  The anti-a mAb and anti-13 mAb 
molecules bound together to the same myosin were identified 
by the location of their binding sites at 61.3  +  5.7 nm (n  = 
37) and 34.3  +  4.4 nm (n  =  37), respectively. Labeling of 
myosin molecules with one anti-or and one anti-13 indicated 
that these myosin molecules were al3-MHC heterodimers. 
Dechesne et al.  Cardiac Myosin Heavy Chain Homodimers and Heterodimers  3033 Figure  2. Gallery of rotary-shadowed al~ MHC heterodimers, labeled by both anti-et and anti-13. The chart indicates, as in Fig. 1, distribution 
of measurements of the distances from the head-tail junction to the two mAb binding sites:  61.3  +  5.7 nm in the case of anti-a,  and 
34.3  +  4.4 nm in the case of anti-13. Bar, 25 nm. 
There were no significant differences in the binding sites of 
either anti-or or anti-13 in this experiment compared with the 
experiments above, in which the mAbs were used separately. 
Quantitative Analysis of Vx, VzV2V3, and V3 Myosins 
The proportions of MHC homodimers and heterodimers  in 
V1,  VIV2V3,  and  V3  myosins  were  investigated  by  simul- 
taneous anti-or and anti-13 labeling of myosin molecules.  Six 
types  of  rotary-shadowed  mAb-myosin  complexes  were 
found based on the numbers of each mAb bound per myosin 
molecule (Fig. 3): complexes with no mAb, a single anti-13, 
two anti-I~, a single anti-a, two anti-a, and an anti-a plus an 
Figure  3. The six types of rotary-shadowed mAb-myosin complexes after simultaneous labeling by anti-or and anti-[3. Number of each mAb 
bound per myosin molecule is indicated under the type of complex. Bar, 25 nm. 
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Figure  4.  Distribution of percentages of the six types of rotary- 
shadowed mAb-myosin complexes observed after  simultaneous 
labeling by anti-a and anti-13. Each type is designated below its bar 
by the number of anti-ct and anti-13 molecules bound per myosin 
molecule, as in Fig. 3. The three histograms represent the results 
from V,V2V3 (n =  130), V3 (n =  38), and Vt (n = 44) myosins, 
respectively. For V~V2V3 myosin, the numbers in parentheses in- 
dicate the theoretical randomly distributed proportions of mAb- 
myosin complexes. For Vt myosin, the asterisks (*) indicate the 
three types of  anti-I]-myosin  complexes  observed in small amounts. 
anti-B. These six types were quantitated on randomly taken 
micrographs. The results are illustrated histographically in 
Fig. 4. All six mAb-myosin complex types were present in 
V,V2V3 myosin, and, in different proportions,  in V~ myo- 
sin. However,  only complexes with one or two anti-13 were 
detected in  V3  myosin.  There  were no  significant differ- 
ences in any of  the mAb binding locations compared with the 
previous experiments using single mAbs. 
In the case of VIV2V3 myosin, the theoretical randomly 
distributed proportions of  the six types of  mAb--myosin com- 
plex were calculated according to the binding characteristics 
of anti-ct and anti-B just determined, and on the basis of the 
amounts of ctct-, ct~, and BB-MHC determined by densito- 
metric scanning (see Materials and Methods). The theoreti- 
cal proportions were not significantly different (P =  0.05) 
from the observed values (see Fig. 4). They were thus in very 
good agreement with the proportions of MHC homodimers 
and heterodimers shown by electrophoresis of myosin under 
nondenaturing conditions. Moreover, this suggests  that the 
binding of anti-ct  and anti-I~ to the same myosin molecule 
represents two independent events. 
Rotary-shadowed molecules of V3 myosin were only la- 
beled with one or two anti-B. Taking into account the binding 
characteristics of anti-B,  both this finding and the propor- 
tions of the two types of mAb-myosin complex observed are 
also in very good agreement with the pure BB-MHC homo- 
dimer content indicated by electrophoresis under nondena- 
turing conditions. 
By contrast, the values observed with V~ myosin do not 
correspond to a pure ctct-MHC homodimer content, as indi- 
cated by electrophoresis under nondenaturing conditions, 
since small amounts of anti-B-myosin complexes were ob- 
served.  An analysis of the distribution of the six mAb-V~- 
myosin complex types using a least squares linear regression 
curve, taking into account the binding characteristics of an- 
ti-ct and anti-B previously determined, gives the following 
proportions: 87 % ctct-MHC homodimers, 9% ct~-MHC het- 
erodimers, and 4% Bf~-MHC homodimers. Thus, there was 
a small amount of [3-MHC in V~ myosin, and it was present 
in both homodimeric and heterodimeric forms. 
Discussion 
In  this  electronmicroscopic  study we  directly visualized 
cardiac ctct-MHC homodimers, I313-MHC homodimers, and 
CtI3-MHC heterodimers, using one anti-ct  MHC mAb and 
one anti-B  MHC mAb directed against different antigenic 
sites on ct- and B-MHC. This visualization demonstrates the 
existence of homodimeric and heterodimeric arrangements 
of a- and I3-MHC in cardiac myosin molecules. The propor- 
tions of ctct-MHC homodimers, ctB-MHC heterodimers, and 
BB-MHC homodirners found in V1V2V3 myosin by our anal- 
ysis of mAb-myosin complexes are in agreement with the 
quantification of the corresponding bands on nondenaturing 
electrophoretic gels, which completely supports the hypoth- 
esis of Hoh et al.  (1979): V~ and V3 bands correspond to 
act- and [3[3-MHC homodimers, respectively, and V2 band 
corresponds to ctB-MHC heterodimers. 
Thus,  the occurrence of a  third type of ventricular rat 
MHC producing the V2 band is highly unlikely. However, 
the possibility cannot be totally excluded. A few works do 
in fact suggest the presence of a third cardiac MHC type. In 
man, a very small amount of ventricular fibers with a special 
MHC content, named B', has been evidenced by immunoflu- 
orescence (Bouvagnet et al.,  1984). In bovine heart heter- 
ogeneities found in the primary sequence of B-MHC also 
suggest the existence ofa B'-MHC (Flink and Morkin, 1984). 
Lastly in the rat, Watras (1981) has suggested a heterogeneity 
of V3 myosin based on an analysis of myosin ATPase activ- 
ity during postnatal development. Although the heterogene- 
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remains to be demonstrated that the same phenomenon is 
responsible for the three results. In any case, our present 
results do not support the hypothesis of a third MHC type 
in rat ventricular myosin. 
With the high sensitivity of electron microscopy, a small 
amount of 15-MHC, not detected by electrophoresis under 
nondenaturing conditions, was found in Vt myosin, in the 
form of homodimeric and heterodimeric MHC. In contrast, 
V3 myosin was found to contain only 15-MHC. These data 
are in agreement with our previous results on rat ventricles 
(Dechesne et al.,  1987): (a)  a  persistence of 13-MHC in 
3-wk-old rat ventricles containing V~ myosin, and (b) only 
15-MHC in fibers of ventricles containing V3 myosin. In the 
former ventricles, myosin with at least one 13-heavy chain 
per molecule was found essentially in the conductive cells. 
It was estimated to amount to 8 +  5 % of total myosin, using 
immunoaffinity chromatography, which is  in good agree- 
ment with the 9% a13-MHC heterodimers and 4% 1513 MHC 
homodimers detected here. Thus, there is always 13-MHC ex- 
pression in the rat ventricle during development, in contrast 
with what has been indicated by electrophoreses under non- 
denaturing conditions. 
The existence of ct13-MHC heterodimers raises the puz- 
zling questions of their role and their molecular assembly, 
considering the functional and structural differences between 
cardiac a- and 13-MHC. Moreover, there are the questions 
of how a molecule with two different MHCs and a thick fila- 
ment containing a mixture of MHC homodimers and hetero- 
dimers could function. It is very likely that MHC heterodi- 
mers have a particular function because they can represent 
as much as 30% of total rat ventricular myosin. A partial so- 
lution may be provided by a determination of the spatial dis- 
tribution of MHC heterodimers at the fiber and myocardial 
levels.  However,  the ultrastructural organization of ct- and 
13-MHC coexpressed in the same cardiac fiber is not yet 
known, and immunological approaches used to evidence re- 
gional distribution of a- and 15-MHC cannot discriminate 
homodimeric and heterodimeric MHC molecules (Gorza et 
al., 1981; Sartore et al., 1981; Bouvagnet et al., 1984; Yazaki 
et al., 1984; Dechesne et al., 1985b; Eisenberg et al., 1985; 
Kuro-o et al.,  1986; Bouvagnet et al.,  1987). Further elu- 
cidation of the  function of MHC  heterodimers  could be 
provided by determining the mechanisms by which ct- and 
13-MHC are arranged into homodimers or heterodimers. No 
such factors have yet been found. By contrast, two factors 
regulating levels  of a- and 13-MHC expression in a  given 
cardiac fiber have been evidenced; i.e., the endogenous thy- 
roid hormone level (Chizzonite and Zak, 1984) and the wall 
stress gradient within the myocardium (Gorza et al.,  1981; 
Bouvagnet et al.,  1985; Einsenberg et al.,  1985; Kuro-o et 
al., 1986; Dechesne et al., in press). This suggests that phys- 
iological regulation determines the relative proportions of 
a- and 13-MHC in each fiber, and that these MHCs are then 
arranged in the three possible dimeric structures, essentially 
according to the overall affinity of a given ct- or 13-MHC for 
another ct- or 13-MHC. To test this hypothesis we are at pres- 
ent  searching  a13-MHC  heterodimers  in  another  cardiac 
model: the human cardiac atrium.  Like rat ventricle, this 
muscle contains a mixture of ct- and 13-MHC even within the 
same fibers (Dechesne et al., 1985a).  If no atrial ct13-MHC 
heterodimers are found, although a- and 15-MHC are coex- 
pressed in the same fiber, this would indicate that a precise 
mechanism induces the heterodimer arrangement of ct- and 
13-MHC in the rat ventricle or represses  it in the human 
atrium. 
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